Fortress Biotech, Inc. (FBIO)

NASDAQ: FBIO · Real-Time Price · USD

2.845

-0.085 (-2.90%)

Aug 25, 2026, 1:24 PM EDT - Market open

Fortress Biotech Financials Overview

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	68.47	63.26	57.68	84.51	75.74	68.79
Revenue Growth	15.46%	9.69%	-31.76%	11.58%	10.11%	50.86%
Gross Profit	43.72	30.44	-20.09	-44.45	-89.91	-92.16
Operating Income	-29.18	-70.22	-106.69	-136.06	-203.56	-179
Net Income	103.37	-1.88	-55.89	-68.67	-94.61	-64.7
Earnings Per Share	3.25	-0.07	-2.69	-8.47	-15.97	-11.88
EPS Growth	-	-	-	-	-	-

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Fortress	-	-	1.5	5.23
Journey	68.18	61.86	56.13	79.18
Avenue	-	1.4	-	-
Checkpoint	-	-	0.04	0.1
Total	68.47	63.26	57.68	84.51

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	196.58	79.38	57.26	80.93	178.27	305.74
Total Debt	53.32	67.22	75.96	88.59	129.4	74.98
Net Cash (Debt)	143.26	12.17	-18.7	-7.67	48.87	230.77
Net Cash Growth	2672.60%	-	-	-	-78.82%	59.95%
Net Cash Per Share	4.50	0.44	-0.90	-0.95	8.25	42.37

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	125.92	-65.78	-80.19	-128.23	-179.4	-116.54
Capital Expenditures	-0.08	-	-	-0.06	-2.72	-4.57
Free Cash Flow	125.84	-65.78	-80.19	-128.29	-182.12	-121.11
Free Cash Flow Growth	-	-	-	-	-	-

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	63.86%	48.11%	-34.82%	-52.60%	-118.70%	-133.97%
Operating Margin	-42.61%	-111.00%	-184.98%	-160.99%	-268.76%	-260.21%
Pretax Margin	213.28%	-53.01%	-209.00%	-181.79%	-281.83%	-238.92%
Profit Margin	150.98%	-2.97%	-96.91%	-81.25%	-124.91%	-94.06%
FCF Margin	183.80%	-103.98%	-139.04%	-151.80%	-240.44%	-176.05%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Forward PE	3.66	0.61	0.61	-	-	-
PS Ratio	1.43	1.80	0.97	0.65	0.94	3.62